(DGAP-Media / 10.07.2013 / 14:06)
PRESS RELEASE
exceet demonstrates its leading role in the field of implants
- Development partnership with Swiss medical device company MyoPowers
Ebbs/Berlin, July 10, 2013 - In cooperation with the Swiss company
MyoPowers Medical Technologies SA and further partners, the two members of
exceet Group SE AEMtec GmbH and Contec GmbH are developing an implant for
the treatment of incontinence. After the first prototypes have successfully
been tested, the phase of industrialisation is due to start after passing
the verification stage, followed by a first clinical trial. The know-how of
the exceet Group in the development and manufacturing of miniaturised
electronic components, modules and systems allows the Swiss producer of
medical devices MyoPowers to further develop modern therapies in the field
of urology and develop an implant that will significantly improve the
quality of life for patients suffering incontinence.
Artificial Urinary Sphincter (AUS) of MyoPowers
The jointly developed implant 'Artificial Urinary Sphincter' is a modular
artificial urethral sphincter for the treatment of incontinence. The
feature that sets it apart is that the physician can postoperatively adjust
the closure force by means of a special remote control. The patient
receives a simple remote control to operate the implant.
For further information, please go to www.myopowers.com.
Unique features
The implant, which can be used to treat female and male patients alike,
will be a global innovation in the field of medical implants for urology
treatments. A special remote control allows the physician to simply adjust
the closing pressure of the implant postoperatively. The product is
expected to significantly improve the quality of life for patients
concerned. 'Such development projects are proof that our technological
know-how in the field of medical devices, particularly concerning implants,
is ideally tailored to the market. Once again, AEMtec and Contec have
managed to demonstrate their extraordinary and outstanding industry
expertise,' says Ulrich Reutner, CEO of exceet Group SE.
Contact:
exceet Group SE
Fabian Rau
Vice President Marketing
E-mail: f.rau@exceet.ch
Tel: +49 (0)172/3653167
Contec GmbH
Contec is the European specialist with long-standing experience in the
development and automated manufacturing of high-quality and complex
electronic modules, components and systems. In the field of medical
devices, for example, Contec assumes the overall responsibility for the
development and manufacturing of medical devices, including the entire
testing strategy and qualification of the test systems, as well as their
approval.
AEMtec GmbH
AEMtec in Berlin offers the development, industrialisation, qualification
and production of miniaturised and complex electronic circuits for
application in Class III (active implants) devices using high-end
chip-level technologies such as COB and Flip Chip. Thanks to the company
being part of a strong group and cooperating with renowned research
institutions, the clients benefit from distinct solution expertise,
state-of-the-art technologies and the flexibility of a medium-sized
enterprise.
exceet Group
exceet Group SE is listed in the Prime Standard of the Frankfurt Stock
Exchange. exceet is among the leading providers of embedded electronics and
security solutions with production facilities in Switzerland, Austria, the
Czech Republic, Germany and the Netherlands.
End of Media Release
=--------------------------------------------------------------------
Issuer: exceet Group SE
Key word(s): Research/Technology
10.07.2013 Dissemination of a Press Release, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
=--------------------------------------------------------------------
Language: English
Company: exceet Group SE
114, avenue Gaston Diderich
L-1420 Luxemburg
Grand Duchy of Luxembourg
Phone: +352 2600 3181
Fax: +352 2600 3133
E-mail: info@exceet.ch
Internet: www.exceet.ch
ISIN: LU0472835155, LU0472839819
WKN: A0YF5P, A1BFHT
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in München
End of News DGAP-Media
=--------------------------------------------------------------------
220629 10.07.2013
(END) Dow Jones Newswires
July 10, 2013 08:05 ET (12:05 GMT)
